BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 8060379)

  • 1. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
    Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Mikami Y; Mikami Y; Nakamura H
    Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Ozawa H; Sakane H; Nakamura H
    Atherosclerosis; 1997 Mar; 129(2):241-8. PubMed ID: 9105567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of eicosapentaenoic acid on plasma lipoprotein subfractions and activities of lecithin:cholesterol acyltransferase and lipid transfer protein.
    Homma Y; Ohshima K; Yamaguchi H; Nakamura H; Araki G; Goto Y
    Atherosclerosis; 1991 Nov; 91(1-2):145-53. PubMed ID: 1811549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.
    Lagrost L; Gandjini H; Athias A; Guyard-Dangremont V; Lallemant C; Gambert P
    Arterioscler Thromb; 1993 Jun; 13(6):815-25. PubMed ID: 8499401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN
    Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin.
    Bisgaier CL; Siebenkas MV; Brown ML; Inazu A; Koizumi J; Mabuchi H; Tall AR
    J Lipid Res; 1991 Jan; 32(1):21-33. PubMed ID: 2010691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients.
    Dullaart RP; Gansevoort RT; Dikkeschei BD; de Zeeuw D; de Jong PE; Van Tol A
    Kidney Int; 1993 Jul; 44(1):91-7. PubMed ID: 8355471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma.
    Freeman DJ; Caslake MJ; Griffin BA; Hinnie J; Tan CE; Watson TD; Packard CJ; Shepherd J
    Eur J Clin Invest; 1998 Jul; 28(7):584-91. PubMed ID: 9726040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia.
    Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Nakamura H
    Atherosclerosis; 1995 Apr; 114(2):223-34. PubMed ID: 7605391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia.
    Gavish D; Oschry Y; Fainaru M; Eisenberg S
    Eur J Clin Invest; 1986 Feb; 16(1):61-8. PubMed ID: 3084275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.
    Ozturk OH; Can Y; Yonden Z; Motor S; Oktay G; Kaya H; Aslan M
    Lipids; 2013 Dec; 48(12):1217-26. PubMed ID: 24113910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
    Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K
    Jpn Circ J; 1999 Jun; 63(6):471-7. PubMed ID: 10406588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities.
    Chiesa G; Michelagnoli S; Cassinotti M; Gianfranceschi G; Werba JP; Pazzucconi F; Sirtori CR; Franceschini G
    Metabolism; 1993 Feb; 42(2):229-35. PubMed ID: 8474321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation.
    Nishiwaki M; Ishikawa T; Ito T; Shige H; Tomiyasu K; Nakajima K; Kondo K; Hashimoto H; Saitoh K; Manabe M
    Atherosclerosis; 1994 Nov; 111(1):99-109. PubMed ID: 7840818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia.
    Guérin M; Dolphin PJ; Talussot C; Gardette J; Berthézène F; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1359-68. PubMed ID: 7670950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
    Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
    Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men.
    Dullaart RP; Hoogenberg K; Dikkeschei BD; van Tol A
    Arterioscler Thromb; 1994 Oct; 14(10):1581-5. PubMed ID: 7918308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
    Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W
    Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.